Drag

Blue Jet Healthcare Limited

Healthcare BLUEJET

413.00INR
-8.30 ( -1.97%)

Last update at

Day Range

410.55425.00
LowHigh

52 Week Range

511.05 1026.00
LowHigh

Fundamentals

  • Previous Close 421.30
  • Market Cap 89232.91M
  • Volume260,986
  • P/E Ratio 25.36
  • EBITDA 4381.76M
  • Revenue TTM 11790.66M
  • Revenue Per Share TTM 67.98
  • Gross Profit TTM 6321.53M
  • Diluted EPS TTM 20.28

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 4060.99M 2200.95M 2166.11M 2432.30M 1846.57M
Net income 3052.03M 1637.51M 1600.27M 1815.91M 1384.15M
Total Revenue 10299.85M 7103.16M 7184.81M 6767.80M 4942.10M
Gross Profit 5687.64M 3891.25M 2703.17M 2965.76M 2474.83M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 14175.31M 10588.47M 8620.65M 7133.75M 5362.70M
Intangible assets 5.13M 1.97M 0.41M - 0.01M
Other current assets 860.10M 903.43M - - -
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -79.75M -244.84M -99.35M 142.46M 510.55M
Operating Cash 457.65M 2412.57M 1415.50M 1464.17M 1299.17M
Free Cash Flow -341.15M 669.59M 822.79M 1207.51M 807.67M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change Price Market Cap (M) P/E Ratio
BLUEJET
Blue Jet Healthcare Limited 		-8.30 -1.97% 413.00 89232.91 25.36
BIOCON
Biocon Limited 		-3.90 -1.05% 368.40 569444.73 94.72
ANTHEM
Anthem Biosciences Ltd 		-0.65 -0.11% 606.75 416096.85 91.92
ONESOURCE
ONESOURCE SPECIALTY PHARMA LTD 		41.20 3.50% 1218.80 203986.14 501.41
CONCORDBIO
Concord Biotech Limited 		19.10 1.64% 1183.20 140309.66 43.31

Profile

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Blue Jet Healthcare Limited

Bhumiraj Costarica, Plot No. 1 & 2, Thane, India, 400705

Key Executives

Name Title Year Born
Mr. Akshay Bansarilal Arora Executive Chairman 1963
Mr. Shiven Akshay Arora MD & Director 1993
Mr. Naresh Suryakant Shah Executive Director 1965
Mr. Ganesh Karuppannan Chief Financial Officer NA
Mr. Vimalendu Kumar Singh Chief Operating Officer NA
Ms. Sweta Poddar Company Secretary & Compliance Officer NA
Ms. Archana Akshay Arora Head of Business Development 1969
Mr. Chandrashekar Parenky President of Research & Development NA
Ms. Payal Gandhi Chief Business Strategy Officer NA
Mr. Sanjay Sinha Deputy Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.